Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 10, 2008, Pages 1135-1141

  Saelee, P ^a,c   Wongkham, S ^b   Bhudhisawasdi, V ^b   Sripa, B ^b   Chariyalertsak, S ^c   Petmitr, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Arbitrarily primed polymerase chain reaction; Chromosome 5q34; Hepatocellular carcinoma; Poor prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DNA FRAGMENT; NUCLEOTIDE;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 5Q; CHROMOSOME 5Q34; CHROMOSOME 6P; CHROMOSOME 6P25.2; CHROMOSOME 8Q; CHROMOSOME 8Q12.1; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MOLECULAR CLONING; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME;

CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 50249097226     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0379-1     Document Type: Article

References (40)

1. A Achille MO Biasi G Zamboni G Bogina AR Magalini P Pederzoli M Perucho A Scarpa 1996 Chromosome 7q allelic losses in pancreatic carcinoma Cancer Res 56 3808 3813
2. S Badvie 2000 Hepatocellular carcinoma Postgrad Med J 76 4 11
3. MA Buendia 2000 Genetics of hepatocellular carcinoma Semin Cancer Biol 10 185 200
4. S Chariyalertsak T Khuhaprema V Bhudisawasdi B Sripa S Wongkham S Petmitr 2005 Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction J Cancer Res Clin Oncol 131 821 828
5. U Chuensumran S Wongkham C Pairojkul S Chauin S Petmitr 2007 Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma World J Gastroenterol 13 2986 2991
6. C de Juan P Iniesta FJ Vega MA Peinado C Fernandez T Caldés MJ Massa JA López A Sánchez AJ Torres JL Balibrea M Benito 1998 Prognostic value of genomic damage in non-small-cell lung cancer Br J Cancer 77 1971 1977
7. A de La Coste B Romagnolo P Billuart CA Renard MA Buendia O Soubrane M Fabre J Chelly C Beldjord A Kahn C Perret 1998 Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas Proc Natl Acad Sci USA 95 8847 8851
8. AT De Souza GR Hankins MK Washington TC Orton RL Jirtle 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity Nat Genet 11 447 449
9. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 462 503
10. H Elmileik AC Paterson MC Kew 2005 Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma J Surg Oncol 91 258 263
11. SW Faulkner DA Leigh JW Oosterhuis H Roelofs LH Looijenga ML Friedlander 2000 Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model Br J Cancer 83 729 736
12. K Fukai O Yokosuka F Imazeki M Tada R Mikata M Miyazaki T Ochiai H Saisho 2005 Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma Liver Int 25 1209 1216
13. S Hosoe K Ueno Y Shigedo I Tachibana T Osaki T Kumagai Y Tanio I Kawase Y Nakamura T Kishimoto 1994 A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung Cancer Res 54 1787 1790
14. LS Hsu HC Lee GY Chau PH Yin CW Chi WY Lui 2006 Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan Oncol Rep 15 507 511
15. HK Johannsdottir G Jonsson G Johannesdottir BA Agnarsson H Eerola A Arason P Heikkila V Egilsson H Olsson OT Johannsson H Nevanlinna A Borg RB Barkardottir 2006 Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors Int J Cancer 119 1052 1060
16. K Kawakami J Yasuda M Shiraishi T Kayama K Doi M Perucho T Sekiya 1998 Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers Biochem Biophys Res Commun 251 153 157
17. T Kohno K Morishita H Takano DN Shapiro J Yokota 1994 Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting Oncogene 9 103 108
18. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 402 408
19. T Maeda A Jikko H Hiranuma H Fuchihata 1999 Analysis of genomic instability in squamous cell carcinoma of the head and neck using the random amplified polymorphic DNA method Cancer Lett 26 183 188
20. A Marchio M Meddeb P Pineau G Danglot P Tiollais A Bernheim A Dejean 1997 Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization Genes Chromosomes Cancer 18 59 65
21. P Mendes-da-Silva A Moreira J Duro-da-Costa D Matias C Monteiro 2000 Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma Mol Pathol 53 184 187
22. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215
23. VV Murty VE Reuter GJ Bosl RS Chaganti 1996 Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors Oncogene 12 2719 2723
24. JM Navarro JL Jorcano 1999 The use of arbitrarily primed polymerase chain reaction in cancer research Electrophoresis 20 283 290
25. N Nishida Y Fukuda H Kokuryu J Toguchida DW Yandell M Ikenega H Imura K Ishizaki 1993 Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma Cancer Res 53 368 372
26. N Nishida Y Fukuda T Komeda R Kita T Sando M Furukawa M Amenomori I Shibagaki K Nakao M Ikenaga K Ishizaki 1994 Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma Cancer Res 54 3107 3110
27. T Pakeetoot P Punyarit S Petmitr 2007 Novel DNA amplification on chromosome 6q23-24 and 4p15.2 in breast cancer identified by arbitrarily primed polymerase chain reaction J Exp Clin Cancer Res 26 253 259
28. DM Parkin P Pisani J Ferlay 1999 Global cancer statistics CA Cancer J Clin 49 33 64
29. MA Peinado S Malkhosyan A Velazquez M Perucho 1992 Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction Proc Natl Acad Sci U S A 89 10065 10069
30. W Pongstaporn M Rochanawutanon S Wilailak V Linasamita S Weerakiat S Petmitr 2006 Genetic alterations in chromosome 10q24.3 and glutathione S- transferase Omega 2 gene polymorphism in ovarian cancer J Exp Clin Cancer Res 25 107 114
31. JC Sheu YW Lin HC Chou GT Huang HS Lee YH Lin SY Huang CH Chen JT Wang PH Lee JT Lin FJ Lu DS Chen 1999 Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan Br J Cancer 80 468 476
32. JH Shin SM Kang YS Kim DH Shin J Chang SK Kim SK Kim 2005 Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma Chest 128 2999 3003
33. KP Singh D Roy 2001 Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting Gene 269 33 43
34. AL Tai WS Yan Y Fang D Xie JS Sham XY Guan 2004 Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence Cancer 100 1918 1927
35. J Welsh M McClelland 1990 Fingerprinting genomes using PCR with arbitrary primers Nucleic Acids Res 18 7213 7218
36. JG Williams AR Kubelik KJ Livak JA Rafalski SV Tingey 1990 DNA polymorphisms amplified by arbitrary primers are useful as genetic markers Nucleic Acids Res 18 6531 6535
37. ZH Xian WM Cong SH Zhang MC Wu 2005 Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment World J Gastroenterol 11 4102 4107
38. MC Yakicier MB Irmak A Romano M Kew M Ozturk 1999 Smad2 and Smad4 gene mutations in hepatocellular carcinoma Oncogene 18 4879 4883
39. X Zhang HJ Xu Y Murakami R Sachse K Yashima S Hirohashi SX Hu WF Benedict T Sekiya 1994 Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma Cancer Res 54 4177 4182
40. GN Zhu L Zuo Q Zhou SM Zhang HQ Zhu SY Gui Y Wang 2004 Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma World J Gastroenterol 10 1975 1978